Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Delayed Quote. Delayed NASDAQ OMX COPENHAGEN - 10/30 11:59:32 am
410.55 DKK   -3.41%
10/30NOVO NORDISK : Gets a Buy rating from Bernstein
MD
10/30NOVO NORDISK A/S : Investor presentation
PU
10/30NOVO NORDISK : Berenberg gives a Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

NOVO NORDISK : Goldman Sachs remains its Buy rating

share with twitter share with LinkedIn share with facebook
08/11/2020 | 02:44am EDT

Goldman Sachs analyst Jonathan Kownator maintains his Buy rating on the stock. The target price has been modified and is now set at DKK 484 compared to DKK 475.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
NOVO NORDISK A/S -3.41% 410.55 Delayed Quote.9.93%
THE GOLDMAN SACHS GROUP, INC. -0.47% 189.04 Delayed Quote.-17.78%
share with twitter share with LinkedIn share with facebook
All news about NOVO NORDISK A/S
10/30NOVO NORDISK : Gets a Buy rating from Bernstein
MD
10/30NOVO NORDISK A/S : Investor presentation
PU
10/30NOVO NORDISK : Berenberg gives a Neutral rating
MD
10/30GLOBAL MARKETS LIVE : Alphabet, Amazon, Starbucks…
10/30NOVO NORDISK A/S : 3Q Net Profit Rose as Pandemic Disruption EaseD -- Earnings R..
DJ
10/30NOVO NORDISK : Jefferies reaffirms its Sell rating
MD
10/30NOVO NORDISK : Gets a Buy rating from JP Morgan
MD
10/30NOVO NORDISK : UBS sticks Neutral
MD
10/30NOVO NORDISK : Goldman Sachs keeps its Buy rating
MD
10/30NOVO NORDISK : 3Q Earnings Snapshot
AQ
More news
Financials
Sales 2020 128 B 19 954 M 19 954 M
Net income 2020 42 215 M 6 604 M 6 604 M
Net cash 2020 10 884 M 1 702 M 1 702 M
P/E ratio 2020 22,4x
Yield 2020 2,17%
Capitalization 954 B 149 B 149 B
EV / Sales 2020 7,39x
EV / Sales 2021 6,91x
Nbr of Employees 43 526
Free-Float 75,1%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 447,63 DKK
Last Close Price 410,55 DKK
Spread / Highest target 32,7%
Spread / Average Target 9,03%
Spread / Lowest Target -25,7%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S9.93%154 639
JOHNSON & JOHNSON-6.01%361 159
ROCHE HOLDING AG-6.40%274 461
PFIZER INC.-9.44%196 047
MERCK & CO., INC.-17.31%191 944
NOVARTIS AG-22.62%176 518